Login
← Go Back
  • Aurobindo Pharma AUROPHARMA ·  8 years, 1 month ago  ·
    Sep 2017 Quarterly Result Announced
    Sep 2017 Sales EBITDA PAT EPS
    Amount 3,074 Cr 1,039 Cr 753 Cr 12.8 Rs
    Growth 18.6% 11.8% 24.3% 23.6%
  • Replied on AUROPHARMA 's post
    Sagar @sagar ·  8 years, 1 month ago  ·
    Why is this down by 4% even if the results were good?
     1
     1
  • Replied on AUROPHARMA 's post
    Kishan @kishan ·  8 years, 1 month ago  ·
    all pharma down due to some unfollowed regulation .. Lupin lost a lot due to some pending clearance from USA approval.
     1
     1
Use @ for users, # for companies and : for emojis
Relevant Companies
Aurobindo Pharma
AUROPHARMA  [LTP: 1,186]
Follow
Mentioned Users
Sagar
sagar
Follow
Don't know what I'm doing . . .
Kishan
kishan
Follow
Trending Today
Leaderboard View more / less  
Loading..
Top Gainers & Losers View more / less
Loading ...